Validation of the therapeutic conduct proposed by artificial intelligence in the context patients with Diabetes mellitus who present hypersensitivity reaction to exogenous insulin
DOI:
https://doi.org/10.33448/rsd-v13i11.47357Keywords:
Case reports; Artificial Intelligence; Diabetes Mellitus.Abstract
Introduction: Artificial Intelligence (AI) is transforming medicine, being able to perform diagnoses and propose therapeutic approaches. One example is Chat GPT, which has been gaining prominence. This study aims to explore the innovation of AI in medicine, highlighting its capabilities and challenges, especially in diagnoses, treatments and patient screening. Methodology: To validate the use of Chat GPT, a qualitative comparative thematic analysis was performed. Three scientific articles on insulin hypersensitivity reactions in patients with Diabetes Mellitus were selected. The cases were submitted to the tool, which suggested therapeutic approaches. These suggestions were then compared with the actual resolutions of physicians in clinical cases. Results: Chat GPT's approaches coincided with those of physicians in several areas, such as insulin desensitization, personalized therapeutic regimen, insulin dosage adjustment, patient education and support, properly operating the DM diagnosis, glycemic control, focus on nursing care, monitoring and follow-up. However, there were divergences regarding the post-desensitization assessment, insulin therapy regimen, and treatment of dermatological complications. Thus, AI has shown to be impactful in the context of medical practice. Conclusion: In complex cases, such as insulin hypersensitivity, AI has shown consistent approaches, even with few precedents in the literature. Thus, the tool stands out as a promising innovation, with the potential to assist in medical practice, due to its reliability and practicality.
References
Brutsaert, E. F. (2023). Cetoacidose diabética (CAD) . Manuais MSD. https://www.msdmanuals.com/pt/profissional/dist%C3%BArbios-end%C3%B3crinos-e-metab%C3%B3licos/diabetes-mellitus-e-dist%C3%BArbios-do- metabolismo-de-carboidratos/cetoacidose-diab%C3%A9tica-cad
CNN Brasil. (2023). ChatGPT supera médicos para fazer diagnóstico em consulta, diz estudo. https://www.cnnbrasil.com.br/tudo-sobre/diagnostico/?amp.
Dahdal, M. (2023). ChatGPT na saúde: o que esperar da relação médico e paciente com o uso do ChatGPT na saúde? https://sanarmed.com/chatgpt-na-saude-o-que-esperar-da-relacao-medico-e-paciente-colunistapremium/
Ferreira, L., Silva, A., & Costa, M. (2022). O papel da tecnologia na gestão do Diabetes Mellitus: uma revisão crítica. Revista Brasileira de Medicina , 75(3), 123-130.
Goldman, L. e Schafer, AI (2022). Goldman-Cecil Medicina (26ª ed.). Grupo GE.
He, F., Xu, L. L., Li, Y. X., & Dong, Y. X. (2022). Nursing a patient with latent autoimmune diabetes in adults with insulin-related lipodystrophy, allergy, and exogenous insulin autoimmune syndrome: A case report. World journal of clinical cases, 10(20), 7163–7170. https://doi.org/10.12998/wjcc.v10.i20.7163
IHU. (2023). Quais os limites do Chat GPT na Saúde? Recuperado de https://www.ihu.unisinos.br/categorias/628012-quais-os-limites-do-chat-gpt-na-saude
Lima, I. (2014). Inteligência Artificial . Grupo GE.
Lima, T., Almeida R., & Santos J. (2023). Diabetes tipo 1 vs tipo 2: implicações clínicas e terapêuticas. Jornal Brasileiro de Endocrinologia , 67(4), 45-60.
Liu, P. R., Lu, L., Zhang, J. Y., Huo, T. T., Liu, S. X., & Ye, Z. W. (2021). Application of Artificial Intelligence in Medicine: An Overview. Current medical science, 41(6), 1105–1115. https://doi.org/10.1007/s11596-021-2474-3
Martins E., & Oliveira F. (2021). Ética na inteligência artificial aplicada à saúde: desafios e oportunidades. Cadernos de Saúde Pública , 37(5), e00012320.
Matos, D. (2023). ChatGPT: Tudo o que você realmente precisa saber, uso e limitações. Recuperado de https://www.cienciaedados.com/chatgpt-tudo-que-voce-realmente-precisa-saber-uso-e-limitacoes/
Moraes J., Ferreira P., & Almeida S. (2022). ChatGPT: potencialidades na prática clínica contemporânea. Revista Brasileira de Telemedicina , 16(2), 99-110.
Nascimento, W. W. D. S. (2023). TCC: O uso do ChatGPT em projetos de gerenciamento.
Nelson, R. W. (2009). Cetoacidose diabética em pequenos animais . Em EC Feldman & RW Nelson (Eds.), Endocrinologia Canina e Felina (pp. 123-134). São Luís: Elsevier.
Pereira A. S. et al. (2018). Metodologia da pesquisa científica. [free e-book]. Santa Maria/RS. Ed. UAB/NTE/UFSM.
Rodrigues, A. T., Garro, L S, Tanno, L K, Motta, A. A. & Ensina, L. F. (2009). Reações de hipersensibilidade à insulina. Revista Brasileira de Alergia e Imunopatologia , 32(6), 217-220.
Rojas, J., Villalobos, M., Martínez, M. S., Chávez-Castillo, M., Torres, W., Mejías, J. C., Miquilena, E., & Bermúdez, V. (2014). Successful management of insulin allergy and autoimmune polyendocrine syndrome type 4 with desensitization therapy and glucocorticoid treatment: a case report and review of the literature. Case reports in immunology, 2014, 394754. https://doi.org/10.1155/2014/394754
Santos J., Oliveira P. & Lima T. (2020). Inteligência artificial em saúde: um novo horizonte para o tratamento personalizado. Revista Brasileira de Saúde Pública , 36(4), 123-130.
Silva A., & Almeida R. (2021). Complicações do Diabetes Mellitus: uma abordagem clínica. Jornal Brasileiro de Medicina Interna , 75(6), 789-795.
Soares, R. A., Pereira, I. S. ., Frazão, M. P. ., Duque, M. de G. C. ., Santos, J. V. F. dos S. dos ., Duque, R. de G. C. ., Pádua, D. M., Martins, J. K. G. da R., Peixoto, J. de O. ., Acácio, M. da S. ., Galvão, A. A. C. . B., & Araújo, S. L. S. de. (2023). O uso da inteligência artificial na medicina: aplicações e benefícios . Research, Society and Development, 12(4), e5012440856. https://doi.org/10.33448/rsd-v12i4.40856
Tian, K., Lee, H. Y., Lim, H. B., Chan, Y. L., Chong, A. H., Rama Chandran, S., & Gardner, D. S. (2021). Rapid Desensitization for Insulin Allergy in Type 1 Diabetes Using an Insulin Pump: A Case Report and Literature Review. AACE clinical case reports, 7(6), 346–349. https://doi.org/10.1016/j.aace.2021.05.004
Vilar L. Endocrinologia Clínica. (7th edição). [Rio de Janeiro]: Grupo GEN; 2020.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Caio Ferreira Fernandes; Pedro Incerte Ayer Pereira; Gerson Hiroshi Yoshinari Júnior
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
